STOCK TITAN

CorMedix Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 13, 2026

(Neutral)
(Neutral)
Tags
earnings date

CorMedix Therapeutics (Nasdaq: CRMD) will release its financial results for the second quarter ended June 30, 2026 before the market opens on Thursday, August 13, 2026. The company will also host a corporate update conference call at 8:30 a.m. Eastern Time the same day.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

Market Context

The tag-specific history averaged -0.51% across two earnings-date notices, providing a mixed compari...
Analysis

The tag-specific history averaged -0.51% across two earnings-date notices, providing a mixed comparison for this scheduling announcement. The active S-3ASR resale registration and absence of company proceeds remain relevant risk context.

Key Figures

Reporting Period: Second quarter 2026 Quarter End: June 30, 2026 Report Date: August 13, 2026 +1 more
4 metrics
Reporting Period Second quarter 2026 Financial results announcement
Quarter End June 30, 2026 Second quarter 2026
Report Date August 13, 2026 Before market open
Conference Call Time 8:30am Eastern Time Corporate update conference call

Previous Earnings date Reports

2 past events · Latest: May 05 (Neutral)
Same Type Pattern 2 events
Date Event Sentiment 24h Move Catalyst
May 05 earnings date Neutral -2.1% Scheduled first-quarter results and corporate update for May 14, 2026
Mar 02 earnings date Neutral +1.1% Scheduled fourth-quarter and full-year results for March 5, 2026

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Tag-specific earnings-date announcements produced mixed reactions, averaging -0.51% across two prior events.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

PARSIPPANY, N.J., July 29, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that it will report its financial results for the second quarter ended June 30, 2026, before the market opens on Thursday, August 13, 2026, and will host a corporate update conference call at 8:30am Eastern Time.

Thursday, August 13th @ 8:30am ET
Domestic:1-844-676-2922
International:1-412-634-6840
Webcast:Webcast Link
  

About CorMedix
CorMedix Therapeutics is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases in the United States. CorMedix is focused on selling and marketing products in institutional settings of care in the US and has field based medical and commercial infrastructure deployed in hospitals, clinics and infusion centers. For more information visit: www.cormedix.com.

Investor Contact:
Dan Ferry
Managing Director
LifeSci Advisors
daniel@lifesciadvisors.com
(617) 430-7576


FAQ

When will CorMedix Therapeutics (CRMD) report Q2 2026 earnings?

CorMedix Therapeutics will report its Q2 2026 financial results on Thursday, August 13, 2026, before the market opens. According to CorMedix Therapeutics, the quarter covers the period ended June 30, 2026.

What time is the CorMedix Therapeutics (CRMD) Q2 2026 earnings conference call?

The CorMedix Therapeutics Q2 2026 corporate update conference call is scheduled for 8:30 a.m. Eastern Time on August 13, 2026. According to CorMedix Therapeutics, the call follows the earnings release earlier that morning.

How can investors join the CorMedix Therapeutics (CRMD) Q2 2026 earnings call by phone?

Investors can join by dialing 1-844-676-2922 domestically or 1-412-634-6840 internationally. According to CorMedix Therapeutics, these numbers provide access to the August 13, 2026 corporate update conference call.

Will the CorMedix Therapeutics (CRMD) Q2 2026 earnings call have a webcast?

Yes, CorMedix Therapeutics will offer a webcast of the August 13, 2026 corporate update call. According to CorMedix Therapeutics, investors can listen via the provided webcast link at the scheduled time.